15: Knowledge management

nork Heisig, Peter
Argitaratua 2024-12-10

Pitfalls in efficacy testing – how important is the validation of neutralization of chlorhexidine digluconate?

nork Reichel, Mirja, Heisig, Peter, Kampf, Günter
Argitaratua 2008

Uncomplicated Urinary Tract Infections and Antibiotic Resistance—Epidemiological and Mechanistic Aspects

nork Wiedemann, Bernd, Heisig, Anke, Heisig, Peter
Argitaratua izan da Antibiotics (Basel) (2014)

Modelling and management of engineering processes

nork Heisig, Peter., Clarkson, P. John., Vajna, Sandor.
Argitaratua 2010.

Impact of gyrA and parC Mutations on Quinolone Resistance, Doubling Time, and Supercoiling Degree of Escherichia coli

nork Bagel, Simone, Hüllen, Volker, Wiedemann, Bernd, Heisig, Peter
Argitaratua 1999

Alcohols for Skin Antisepsis at Clinically Relevant Skin Sites

nork Reichel, Mirja, Heisig, Peter, Kohlmann, Thomas, Kampf, Günter
Argitaratua 2009

In Vivo Increase in Resistance to Ciprofloxacin in Escherichia coli Associated with Deletion of the C-Terminal Part of MarR

nork Linde, Hans-Jörg, Notka, Frank, Metz, Michaela, Kochanowski, Bernd, Heisig, Peter, Lehn, Norbert
Argitaratua 2000

Comparative Activities of Clinafloxacin, Grepafloxacin, Levofloxacin, Moxifloxacin, Ofloxacin, Sparfloxacin, and Trovafloxacin and Nonquinolones Linozelid, Quinupristin-Dalfoprist...

nork Jones, Mark E., Visser, Maarten R., Klootwijk, Miriam, Heisig, Peter, Verhoef, Jan, Schmitz, Franz-Josef
Argitaratua 1999

Resistance to Moxifloxacin in Toxigenic Clostridium difficile Isolates Is Associated with Mutations in gyrA

nork Ackermann, Grit, Tang, Yajarayma J., Kueper, Robert, Heisig, Peter, Rodloff, Arne C., Silva, Joseph, Cohen, Stuart H.
Argitaratua 2001

A Mutation in Escherichia coli DNA Gyrase Conferring Quinolone Resistance Results in Sensitivity to Drugs Targeting Eukaryotic Topoisomerase II

nork Gruger, Thomas, Nitiss, John L., Maxwell, Anthony, Zechiedrich, E. Lynn, Heisig, Peter, Seeber, Siegfried, Pommier, Yves, Strumberg, Dirk
Argitaratua 2004

Prevalence of gyrA, gyrB, parC, and parE Mutations in Clinical Isolates of Streptococcus pneumoniae with Decreased Susceptibilities to Different Fluoroquinolones and Originating fr...

nork Jones, Mark E., Sahm, Daniel F., Martin, Nele, Scheuring, Sibylle, Heisig, Peter, Thornsberry, Clyde, Köhrer, Karl, Schmitz, Franz-Josef
Argitaratua 2000

Association of Alterations in ParC and GyrA Proteins with Resistance of Clinical Isolates of Enterococcus faecium to Nine Different Fluoroquinolones

nork Brisse, Sylvain, Fluit, Ad C., Wagner, Ulrich, Heisig, Peter, Milatovic, Dana, Verhoef, Jan, Scheuring, Sybille, Köhrer, Karl, Schmitz, Franz-Josef
Argitaratua 1999

In Vitro Development of Resistance to Six Quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus

nork Boos, Mechthild, Mayer, Susanne, Fischer, Ansgar, Köhrer, Karl, Scheuring, Sibylle, Heisig, Peter, Verhoef, Jan, Fluit, Ad C., Schmitz, F.-J.
Argitaratua 2001

In Vitro Activities of Fluoroquinolones against the Spirochete Borrelia burgdorferi

nork Kraiczy, Peter, Weigand, Judith, Wichelhaus, Thomas A., Heisig, Peter, Backes, Herbert, Schäfer, Volker, Acker, Georg, Brade, Volker, Hunfeld, Klaus-Peter
Argitaratua 2001

Commonality among Fluoroquinolone-Resistant Sequence Type ST131 Extraintestinal Escherichia coli Isolates from Humans and Companion Animals in Australia

nork Platell, Joanne L., Cobbold, Rowland N., Johnson, James R., Heisig, Anke, Heisig, Peter, Clabots, Connie, Kuskowski, Michael A., Trott, Darren J.
Argitaratua 2011

Prominence of an O75 Clonal Group (Clonal Complex 14) among Non-ST131 Fluoroquinolone-Resistant Escherichia coli Causing Extraintestinal Infections in Humans and Dogs in Australia

nork Platell, Joanne L., Trott, Darren J., Johnson, James R., Heisig, Peter, Heisig, Anke, Clabots, Connie R., Johnston, Brian, Cobbold, Rowland N.
Argitaratua 2012